PharmChem, Inc. Merges with Alcohol Monitoring Systems, Inc.
PharmChem, Inc. (OTC: PCHM), known for its innovative sweat patches used to detect drug abuse, has entered into a landmark agreement with Alcohol Monitoring Systems, Inc. This acquisition will allow PharmChem to expand its reach and enhance its offerings to customers. Shareholders of PharmChem will benefit from a cash payment of $3.75 per share as part of the arrangement.
Details of the Acquisition Agreement
The acquisition agreement signifies a substantial 22% premium over PharmChem's recent closing value. This milestone illustrates the confidence in PharmChem’s position within the market. Board Chairman Tim Eriksen expressed optimism regarding the deal, citing the potential for greater value when combined with a larger company.
Strategic Growth Opportunities
Thompson Clark, Interim CEO of PharmChem, highlighted the thorough process leading to this merger and the significant interest from various parties. The collaboration with Alcohol Monitoring Systems, Inc. is seen as a win for all stakeholders, promising to enhance product distribution, customer service, and employee growth.
Commitment to Public Safety
Chris Linthwaite, CEO of Alcohol Monitoring Systems, emphasized the critical nature of the acquisition in terms of public safety. By integrating PharmChem's drug testing capabilities, the organization can better serve its customers who face complex challenges in ensuring safety compliance. The merger enhances their existing portfolio of alcohol monitoring technologies.
Next Steps for Shareholders
The acquisition is pending approval from PharmChem's shareholders, alongside customary closing conditions. Encouragingly, 52% of outstanding shares have already pledged support for the transaction. A shareholder vote will occur in the upcoming days, with further details forthcoming. This level of support is critical for the merger to proceed smoothly.
About PharmChem, Inc.
PharmChem, Inc. (OTC: PCHM) is recognized as the leading manufacturer and exclusive supplier of the PharmChek Drugs of Abuse Sweat Patch. The company is dedicated to creating products that not only meet the needs of their clients but also contribute positively to society. Their commitment to innovation positions them as a critical component in the fight against drug abuse.
Frequently Asked Questions
What does the acquisition mean for PharmChem, Inc.?
The acquisition by Alcohol Monitoring Systems, Inc. will enhance PharmChem's growth opportunities, allowing for better product outreach and customer support.
How much will PharmChem shareholders receive?
Shareholders will receive $3.75 per share in cash, which represents a 22% premium over the last closing share price before the announcement.
When will the acquisition be finalized?
The transaction is expected to complete before the end of the third quarter, contingent on shareholder approval and other customary conditions.
Who is leading PharmChem during this transition?
Thompson Clark is currently serving as the Interim CEO during the transition and providing guidance through this pivotal time.
What is PharmChem's main product?
PharmChem specializes in the manufacture of sweat patches designed to detect drugs of abuse efficiently, aimed at improving compliance and safety in various sectors.
